# K173128: Alamo® C

- Pathway: 510(k) (Traditional)
- Applicant: Alliance Partners, LLC
- Decided: Mar 22, 2018 after 174 days
- Product code: ODP (Intervertebral Fusion Device With Bone Graft, Cervical)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 14 generations back to K003155 (2001). 103 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 106 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133321: Alamo C, Alliance Partners, LLC (2014) Summary page 4.
- K112361: Alamo C, Alliance Partners, LLC (2011) Summary page 4.
- K161127: The Small PLATEAU (PLATEAU-C) Spacer System, Life Spine, Inc. (2016) Summary page 4.
- K111272: Rhausler Plage Anterior Cervical Fusion System, Rhausler, Inc. (2011) Summary page 4.
- K141993: Nakoma Acp, Alliance Partners, LLC (2014) Summary page 4.

## Most influential descendants
- K252737: DeGen Medical Latitude-C AM Cervical Interbody Fusion System (2025), 0 descendants of its own
- K213115: CHENA-C Spacer System (2021), 0 descendants of its own

## Indications for use
The Alamo® C is indicated for anterior cervical interbody fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one level from C2-T1. DDD is defined as discogenic pain with the degeneration of the disc confirmed by history and radiographic studies. These patients should have had six weeks of non-operative treatment prior to treatment with an intervertebral cage. The device system must be used with supplemental fixation and autograft to facilitate fusion and is to be implanted via an open, anterior approach.

Source page: https://510kreport.com/device/K173128
Methodology: https://510kreport.com/methodology